{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:19:53Z","timestamp":1773065993382,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T00:00:00Z","timestamp":1360800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/jhg.2013.8","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T07:18:37Z","timestamp":1360826317000},"page":"254-258","source":"Crossref","is-referenced-by-count":19,"title":["A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy"],"prefix":"10.1038","volume":"58","author":[{"given":"Kentaro","family":"Toyota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuto","family":"Masakane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Degawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Umetsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Tamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Hayasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,14]]},"reference":[{"key":"BFjhg20138_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/j.ajkd.2005.10.017","volume":"47","author":"T Saito","year":"2006","unstructured":"Saito, T., Matsunaga, A. & Oikawa, S. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am. J. Kidney Dis 47, 199\u2013211 (2006).","journal-title":"Am. J. Kidney Dis"},{"key":"BFjhg20138_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0272-6386(89)80134-9","volume":"13","author":"T Saito","year":"1989","unstructured":"Saito, T., Sato, H., Kudo, K., Oikawa, S., Shibata, T., Hara, Y. et al. Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am. J. Kidney Dis. 13, 148\u2013153 (1989).","journal-title":"Am. J. Kidney Dis."},{"key":"BFjhg20138_CR3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1681\/ASN.V85820","volume":"8","author":"S Oikawa","year":"1997","unstructured":"Oikawa, S., Matsunaga, A., Saito, T., Sato, H., Seki, T., Hoshi, K. et al. Apolipoprotein E Sendai (arginine 145\u2192proline): a new variant associated with lipoprotein glomerulopathy. J. Am. Soc. Nephrol. 8, 820\u2013823 (1997).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFjhg20138_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/MOL.0b013e328345ebb0","volume":"22","author":"V Tsimihodimos","year":"2011","unstructured":"Tsimihodimos, V. & Elisaf, M. Lipoprotein glomerulopathy. Curr. Opin. Lipidol. 22, 262\u2013269 (2011).","journal-title":"Curr. Opin. Lipidol."},{"key":"BFjhg20138_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10157-009-0207-1","volume":"13","author":"A Matsunaga","year":"2009","unstructured":"Matsunaga, A., Furuyama, M., Hashimoto, T., Toyota, K., Ogino, D. & Hayasaka, K. Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy. Clin. Exp. Nephrol 13, 659\u2013662 (2009).","journal-title":"Clin. Exp. Nephrol"},{"key":"BFjhg20138_CR6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3165\/jjpn.24.218","volume":"24","author":"T Hashimoto","year":"2011","unstructured":"Hashimoto, T., Toyota, K., Ogino, D., Matsunaga, A. & Hayasaka, K. A second pediatric patient with lipoprotein glomerulopathy carrying a heterozygous APOE-Sendai mutation. Jpn. J. Pediatr. Nephrol. 24, 218\u2013223 (2011).","journal-title":"Jpn. J. Pediatr. Nephrol."},{"key":"BFjhg20138_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.5551\/jat.8102","volume":"18","author":"T Tokura","year":"2011","unstructured":"Tokura, T., Itano, S., Kobayashi, S., Kuwabara, A., Fujimoto, S., Horike, H. et al. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy. J. Atheroscler. Thromb. 18, 536\u2013541 (2011).","journal-title":"J. Atheroscler. Thromb."},{"key":"BFjhg20138_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5551\/jat.7377","volume":"18","author":"A Mitani","year":"2011","unstructured":"Mitani, A., Ishigami, M., Watase, K., Minakata, T. & Yamamura, T. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy. J. Atheroscler. Thromb. 18, 531\u2013535 (2011).","journal-title":"J. Atheroscler. Thromb."},{"key":"BFjhg20138_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.5414\/CN106876","volume":"78","author":"MT Liao","year":"2012","unstructured":"Liao, M. T., Tsai, I. J., Cheng, H. T., Lin, W. C., Chang, Y. W., Lin, Y. H. et al. A rare cause of childhood-onset nephrotic syndrome: lipoprotein glomerulopathy. Clin. Nephrol. 78, 237\u2013240 (2012).","journal-title":"Clin. Nephrol."},{"key":"BFjhg20138_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1053\/ajkd.2003.50016","volume":"41","author":"N Ieiri","year":"2003","unstructured":"Ieiri, N., Hotta, O. & Taguma, Y. Resolution of typical lipoprotein glomerulopathy. Am. J. Kidney. Dis. 41, 244\u2013249 (2003).","journal-title":"Am. J. Kidney. Dis."},{"key":"BFjhg20138_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0021-9150(03)00194-1","volume":"169","author":"T Arai","year":"2003","unstructured":"Arai, T., Yamashita, S., Yamane, M., Manabe, N., Matsuzaki, T., Kiriyama, K. et al. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy. Atherosclerosis 169, 293\u2013299 (2003).","journal-title":"Atherosclerosis"},{"key":"BFjhg20138_CR12","first-page":"41","volume":"30","author":"S Nomachi","year":"2003","unstructured":"Nomachi, S., Tagami, Y., Nakazawa, E., Midzushima, Y., Ozaki, T., Fujita, K. et al. Genetic diagnostic scheme for adult-onset type 2 citrullinemia using dried blood samples. Annu. Rep. Sapporo City Institute Public Health 30, 41\u201346 (2003).","journal-title":"Annu. Rep. Sapporo City Institute Public Health"},{"key":"BFjhg20138_CR13","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1086\/303070","volume":"67","author":"SM Fullerton","year":"2000","unstructured":"Fullerton, S. M., Clark, A. G., Weiss, K. M., Nickerson, D. A., Taylor, S. L., Steng\u00e2rd, J. H. et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am. J. Hum. Genet. 67, 881\u2013900 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg20138_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/j.ajkd.2005.12.031","volume":"47","author":"R Sam","year":"2006","unstructured":"Sam, R., Wu, H., Yue, L., Mazzone, T., Schwartz, M. M., Arruda, J. A. et al. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding. Am. J. Kidney Dis. 47, 539\u2013548 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"BFjhg20138_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000111828","volume":"28","author":"B Luo","year":"2008","unstructured":"Luo, B., Huang, F., Liu, Q., Li, X., Chen, W., Zhou, S. F. et al. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy. Am. J. Nephrol. 28, 347\u2013353 (2008).","journal-title":"Am. J. Nephrol."},{"key":"BFjhg20138_CR16","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1093\/ndt\/gfq389","volume":"25","author":"AS Bomback","year":"2010","unstructured":"Bomback, A. S., Song, H., D\u2019Agati, V. D., Cohen, S. D., Neal, A., Appel, G. B. et al. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy. Nephrol. Dial. Transplant. 25, 3442\u20133446 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFjhg20138_CR17","doi-asserted-by":"publisher","first-page":"9311","DOI":"10.1186\/1752-1947-3-9311","volume":"3","author":"G Russi","year":"2009","unstructured":"Russi, G., Furci, L., Leonelli, M., Minnei, F., Magistroni, R., Romano, N. et al. Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced extracorporeal lipoprotein precipitation system.): a case report. J. Med. Case Rep 3, 9311 (2009).","journal-title":"J. Med. Case Rep"},{"key":"BFjhg20138_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1046\/j.1523-1755.1999.00572.x","volume":"56","author":"A Matsunaga","year":"1999","unstructured":"Matsunaga, A., Sasaki, J., Komatsu, T., Kanatsu, K., Tsuji, E., Moriyama, K. et al. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. Kidney Int. 56, 421\u2013427 (1999).","journal-title":"Kidney Int."},{"key":"BFjhg20138_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s004670050032","volume":"14","author":"T Ogawa","year":"2000","unstructured":"Ogawa, T., Maruyama, K., Hattori, H., Arai, H., Kondoh, I., Egashira, T. et al. A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy. Pediatr. Nephrol. 14, 149\u2013151 (2000).","journal-title":"Pediatr. Nephrol."},{"key":"BFjhg20138_CR20","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1056\/NEJMc072088","volume":"357","author":"BH Rovin","year":"2007","unstructured":"Rovin, B. H., Roncone, D., Mckinley, A., Nadasdy, T., Korbet, S. M. & Schwartz, M. M. APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy. N. Engl. J. Med. 357, 2522\u20132524 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg20138_CR21","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1053\/j.ajkd.2004.08.048","volume":"45","author":"K Foster","year":"2005","unstructured":"Foster, K., Matsunaga, A., Matalon, R., Saito, T., Gallo, G., Agati, V. D. et al. A rare cause of posttransplantation nephrotic syndrome. Am. J. Kidney Dis. 45, 1132\u20131138 (2005).","journal-title":"Am. J. Kidney Dis."},{"key":"BFjhg20138_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000045513","volume":"83","author":"K Konishi","year":"1999","unstructured":"Konishi, K., Saruta, T., Kuramochi, S., Oikawa, S., Saito, T., Han, H. et al. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy. Nephron 83, 214\u2013218 (1999).","journal-title":"Nephron"},{"key":"BFjhg20138_CR23","doi-asserted-by":"publisher","first-page":"c260","DOI":"10.1159\/000276578","volume":"114","author":"J Han","year":"2010","unstructured":"Han, J., Pan, Y., Chen, Y., Li, X., Xing, G., Shi, J. et al. Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China. Nephron Clin. Pract. 114, c260\u2013c267 (2010).","journal-title":"Nephron Clin. Pract."},{"key":"BFjhg20138_CR24","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.89.5.1827","volume":"89","author":"M Frommer","year":"1992","unstructured":"Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W. et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89, 1827\u20131831 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg20138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg20138","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg20138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:32:17Z","timestamp":1684431137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg20138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFjhg20138"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2013.8","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}